ArticleActa pharmacologica Sinica2022

ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway.

Sha Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.